• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Poster Presentations

2026 Poster Presentations

 

← Back to Previous Page

 

P002: PHOSPHATURIC MESENCHYMAL TUMOR OF THE OLFACTORY GROOVE
Rita Snyder, MD; Leomar Y Ballester, MD, PhD; Sujit Prabhu, MD; MD Anderson Cancer Center

Background: Phosphaturic mesenchymal tumors (PMT) are rare, typically benign neoplasms which most frequently arise in the extremities.1,2 Patients often present with osteomalacia due to decreased renal reabsorption of phosphate, and downregulation of 25-hydroxyvitamin D3-1a-hydroxylase caused by Fibroblast growth factor 23 (FGF-23) excreted by the tumor.2 Serum and urine studies may help confirm the diagnosis. Considering this etiology when patients present with a history of unexplained recurrent fractures in the presence of an extra-axial skull base lesion may influence treatment planning as complete resection is curative.2 Here we discuss a case of PMT mimicking an olfactory groove meningioma and subsequent clinical management.

Objective: To improve recognition of a rare etiology of skull base neoplasia and review subsequent treatment considerations.

Methods: A case study and review of the literature was performed. The PUBMED database was searched for articles with the keywords: "phosphaturic mesenchymal tumor" AND "skull base".  

Results: A total of 18 studies were returned, 5 of which were review articles. Of the 37 published cases in the literature to date, only 9 were found isolated to the anterior cranial fossa.2 Regarding our case, a 59-year-old woman was referred to endocrinology after presenting with multiple spontaneous fractures. FGF-23 level was elevated, prompting work-up for underlying malignancy. Serum Vitamin D and phosphorus were deficient; however, bone density scans of the spine and forearm were normal. A right frontal extra-axial lesion arising from the olfactory groove was discovered on MRI brain (Figure 1). The patient was otherwise asymptomatic. She underwent uneventful resection of this lesion, and her phosphate levels normalized one month postoperatively. Intraoperatively and histopathologically the lesion was locally invasive (Figure 2). Dotatate-PET confirmed complete resection (Figure 3). 

Figure 1. Preoperative (A&B) and postoperative (C&D) contrasted MRI scans of right PMT mimicking an olfactory groove meningioma.

Figure 2. Histopathology slides of resected PMT demonstrating A) bland spindle cells, a vascular rich network, and alternating mature adipocytic areas on H&E stain and B) low field Ki67 antigen (MIB1) labelling index of 7.68% (1,003 nuclei counted), with an average index of 5.17%.

Figure 3. Preoperative (A) and postoperative (B) Dotatate-PET study demonstrating complete resection of the highly avid right anterior fossa PMT.

Conclusion: Skull base phosphaturic mesenchymal tumors are a rare etiology in which patients typically present with osteomalacia. It may mimic meningioma on both MRI and PET imaging, therefore serum and urine studies may be helpful for preoperative diagnosis. Gross total resection is curative. Confirmation of complete resection may be obtained with a postoperative Dotatate PET scan.

References:

1. Zhiqing H, Keshuang W, Minghui Z, Jiace Q, Qianhui Q. Phosphaturic mesenchymal tumor of the skull base presenting with tumor-induced osteomalacia and multiple fractures: a case report. J Med Case Rep. 2025 May 5;19(1):208. 

2. Sánchez Muñoz R, Sanmillan JL, Vidal Sarró N, Martín Quintero G, Martí Duce D, Gabarrós Canals A. Intracranial Phosphaturic Mesenchymal Tumors: A Systematic Literature Review of a Rare Entity. World Neurosurg. 2024 Jul;187:70-81. 

View Poster

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved